These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18987645)

  • 21. Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1.
    Miknis ZJ; Magracheva E; Li W; Zdanov A; Kotenko SV; Wlodawer A
    J Mol Biol; 2010 Dec; 404(4):650-64. PubMed ID: 20934432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
    Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
    FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.
    Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
    J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III interferons (IFNs): Emerging Master Regulators of Immunity.
    Galani IE; Koltsida O; Andreakos E
    Adv Exp Med Biol; 2015; 850():1-15. PubMed ID: 26324342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-lambda: a new addition to an old family.
    Donnelly RP; Kotenko SV
    J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra.
    Megjugorac NJ; Gallagher GE; Gallagher G
    Blood; 2010 May; 115(21):4185-90. PubMed ID: 20233967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1.
    Sun H; Bi L; Zhou J; Zhou D; Liu Y; Jin G; Yan W
    Int J Clin Exp Pathol; 2015; 8(2):1743-51. PubMed ID: 25973063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activity of interleukins-28 and -29: comparison with type I interferons.
    Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
    Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ran binding protein 9 (RanBPM) binds IFN-λR1 in the IFN-λ signaling pathway.
    Zhang J; Cong X; Zhaoqiao J; Yang X; Li M; Chen H; Mi R; Jin G; Liu F; Huang BR
    Sci China Life Sci; 2017 Sep; 60(9):1030-1039. PubMed ID: 28547582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells.
    Tezuka Y; Endo S; Matsui A; Sato A; Saito K; Semba K; Takahashi M; Murakami T
    Lung Cancer; 2012 Dec; 78(3):185-92. PubMed ID: 23021208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of IFN-λ1 promoter activity (IFN-λ1/IL-29) in human airway epithelial cells.
    Siegel R; Eskdale J; Gallagher G
    J Immunol; 2011 Dec; 187(11):5636-44. PubMed ID: 22058416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and establishment of type IV interferon and the characterization of interferon-υ including its class II cytokine receptors IFN-υR1 and IL-10R2.
    Chen SN; Gan Z; Hou J; Yang YC; Huang L; Huang B; Wang S; Nie P
    Nat Commun; 2022 Feb; 13(1):999. PubMed ID: 35194032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon lambda-2 levels in sputum of patients with pulmonary Mycobacterium tuberculosis infection.
    Travar M; Vucic M; Petkovic M
    Scand J Immunol; 2014 Jul; 80(1):43-9. PubMed ID: 24684674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.
    Eberle KC; McGill JL; Reinhardt TA; Sacco RE
    J Virol; 2015 Dec; 90(6):2948-58. PubMed ID: 26719274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of IFN-λ in tetrapod vertebrates and its functional characterization in green anole lizard (Anolis carolinensis).
    Chen SN; Zhang XW; Li L; Ruan BY; Huang B; Huang WS; Zou PF; Fu JP; Zhao LJ; Li N; Nie P
    Dev Comp Immunol; 2016 Aug; 61():208-24. PubMed ID: 27062970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
    Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
    PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
    Ilyushina NA; Lugovtsev VY; Samsonova AP; Sheikh FG; Bovin NV; Donnelly RP
    PLoS One; 2017; 12(7):e0181999. PubMed ID: 28750037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel type III interferons produce anti-tumor effects through multiple functions.
    Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M
    Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferons lambda, new cytokines with antiviral activity.
    Lopušná K; Režuchová I; Betáková T; Skovranová L; Tomašková J; Lukáčiková L; Kabát P
    Acta Virol; 2013; 57(2):171-9. PubMed ID: 23600875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type III Interferons in Hepatitis C Virus Infection.
    Boisvert M; Shoukry NH
    Front Immunol; 2016; 7():628. PubMed ID: 28066437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.